Monday 15 December | 10:10:58 Europe / Stockholm

Subscription

Calendar

Est. time*
2024-03-26 - Year-end Report 2023
2023-12-22 - Extra General Meeting 2023
2023-11-23 - Quarterly Report 2023-Q3
2023-08-11 - Quarterly Report 2023-Q2
2023-05-17 - Ex-date Ordinary Dividend COALA 0.00 SEK
2023-05-16 - Annual General meeting
2023-05-04 - Quarterly Report 2023-Q1
2023-03-31 - Year-end Report 2022
2023-01-26 - Extra General Meeting 2022
2022-11-16 - Quarterly Report 2022-Q3
2022-08-17 - Quarterly Report 2022-Q2
2022-05-31 - Ex-date Ordinary Dividend COALA 0.00 SEK
2022-05-30 - Annual General meeting
2022-05-24 - Quarterly Report 2022-Q1
2022-05-04 - Quarterly Report 2022-Q1
2022-02-23 - Year-end Report 2021
2021-12-14 - Ex-date Ordinary Dividend COALA 0.00 SEK
2021-11-04 - Split COALA 50:1
2021-10-29 - Extra General Meeting 2021
2021-08-10 - Extra General Meeting 2021
2021-06-24 - Quarterly Report 2021-Q3
2021-03-25 - Quarterly Report 2021-Q2
2020-12-23 - Ex-date Ordinary Dividend COALA 0.00 SEK
2020-12-22 - Annual General meeting
2020-12-22 - Quarterly Report 2021-Q1
2020-10-22 - Year-end Report 2020
2020-06-25 - Quarterly Report 2020-Q3
2020-03-26 - Quarterly Report 2020-Q2
2019-12-20 - Ex-date Ordinary Dividend COALA 0.00 SEK
2019-12-19 - Annual General meeting
2019-12-12 - Quarterly Report 2020-Q1
2019-10-30 - Extra General Meeting 2019
2019-10-10 - Year-end Report 2019
2019-06-26 - Quarterly Report 2019-Q3
2019-03-26 - Quarterly Report 2019-Q2
2018-12-21 - Ex-date Ordinary Dividend COALA 0.00 SEK
2018-12-20 - Annual General meeting
2018-12-20 - Quarterly Report 2019-Q1
2018-10-11 - Year-end Report 2018
2018-03-27 - Quarterly Report 2018-Q2
2017-12-22 - Ex-date Ordinary Dividend COALA 0.30 SEK
2017-12-21 - Annual General meeting
2017-10-12 - Year-end Report 2017
2017-07-21 - Quarterly Report 2018-Q1
2017-06-21 - Quarterly Report 2017-Q3
2017-03-27 - Quarterly Report 2017-Q2
2016-12-22 - Ex-date Ordinary Dividend COALA 0.25 SEK
2016-12-21 - Annual General meeting
2016-12-21 - Quarterly Report 2017-Q1
2016-10-19 - Year-end Report 2016
2016-06-23 - Quarterly Report 2016-Q3
2016-03-24 - Quarterly Report 2016-Q2
2015-12-18 - Ex-date Ordinary Dividend COALA 0.25 SEK
2015-12-17 - Annual General meeting
2015-12-17 - Quarterly Report 2016-Q1
2015-10-22 - Year-end Report 2015
2015-06-23 - Quarterly Report 2015-Q3
2015-03-26 - Quarterly Report 2015-Q2
2014-12-19 - Ex-date Ordinary Dividend COALA 0.00 SEK
2014-12-18 - Annual General meeting
2014-12-18 - Quarterly Report 2015-Q1
2014-10-23 - Year-end Report 2014
2014-06-26 - Quarterly Report 2014-Q3
2014-04-02 - Quarterly Report 2014-Q2
2014-01-17 - Ex-date Ordinary Dividend COALA 0.00 SEK
2014-01-16 - Annual General meeting
2014-01-15 - Quarterly Report 2014-Q1
2013-10-31 - Analyst Meeting 2013
2013-10-31 - Year-end Report 2013
2013-06-27 - Quarterly Report 2013-Q3
2013-06-05 - Split COALA 200:1
2013-03-27 - Extra General Meeting 2013
2013-03-25 - Quarterly Report 2013-Q2
2013-01-18 - Ex-date Ordinary Dividend COALA 0.00 SEK
2013-01-17 - Annual General meeting
2013-01-16 - Quarterly Report 2013-Q1
2012-10-24 - Year-end Report 2012
2012-06-27 - Quarterly Report 2012-Q3
2012-03-30 - Quarterly Report 2012-Q2
2012-01-20 - Ex-date Ordinary Dividend COALA 0.00 SEK
2012-01-19 - Annual General meeting
2012-01-18 - Quarterly Report 2012-Q1
2011-10-27 - Year-end Report 2011
2011-06-30 - Quarterly Report 2011-Q3
2011-04-06 - Quarterly Report 2011-Q2
2011-01-21 - Ex-date Ordinary Dividend COALA 0.00 SEK
2011-01-20 - Annual General meeting
2011-01-19 - Quarterly Report 2011-Q1
2010-10-22 - Quarterly Report 2010-Q3
2010-10-21 - Year-end Report 2010
2010-06-23 - Quarterly Report 2010-Q2
2010-03-26 - Quarterly Report 2010-Q1
2010-01-13 - Quarterly Report 2009-Q1
2009-10-22 - Quarterly Report 2009-Q3
2009-06-17 - Quarterly Report 2009-Q2
2009-01-28 - Annual General meeting
2006-03-01 - Split COALA 1:2
2005-05-04 - Split COALA 1:2

Description

CountrySweden
SectorHealth care
IndustryMedical technology
Coala Life is active in medical technology focused on smartphone and cloud-based cardiac and pulmonary diagnostics. The company has developed and launched Coala Heart Monitor, a product platform that enables long-term monitoring, analysis, and algorithm-based diagnosis of heart and lungs remotely. The company is active in Europe and the USA with headquarters in Uppsala.

Interested in the company’s key figures?

Analyze the company in Börsdata!

Who owns the company?

Find all ownership data in Holdings!

2023-09-11 11:00:00

Coala-Life Group AB (publ) (“Coala Life” or the “Company”) issued, in conjunction with a rights issue of units during the first quarter of 2023, a total of 164,979,967 warrants of series TO 1 (the “Warrants”). The exercise period for the Warrants begins today, September 11, 2023, and runs until and including September 22, 2023. Three (3) Warrants entitle the holder to subscribe for one (1) new share in the Company. The exercise price per share has been set to SEK 0.25. Upon exercise of all Warrants, Coala Life will receive approximately SEK 13,7 million before issue costs.

Exercise of Warrants in summary

  • The exercise period for the Warrants runs from September 11, 2023, until and including September 22, 2023.
  • Three (3) Warrants entitle the holder to subscribe for one (1) new share in the Company at the exercise price of SEK 0.25 per share.
  • The Warrants will be traded on Nasdaq First North Growth Market until and including September 20, 2023.
  • Warrants that have not been exercised for subscription of new shares on September 22, 2023, at the latest, will expire without value.
  • Holders of Warrants who have their holdings nominee-registered must notify their respective nominee of their intention to exercise their Warrants, for further instructions regarding subscription and payment. This should be done well in advance of September 22, 2023, as nominees have varying processing times.
  • Holders of Warrants who have their holdings directly registered must fill out and submit a particular application form for the exercise, so that the application form is received by the issuing agent Nordic Issuing by September 22, 2023, at the latest. The form is available on the Company’s, Nordic Issuing AB’s, and Redeye’s respective websites (www.coalalife.comwww.nordic-issuing.sewww.redeye.se).
  • Upon exercise of all Warrants, Coala Life will receive approximately SEK 13.7 million before issue costs, which are estimated to amount to approximately SEK 1 million, primarily attributable to advisor fees and processing costs.
  • The exercise price of SEK 0.25 per new share has been set in accordance with the terms and conditions for the Warrants, according to which the exercise price per new share shall correspond to seventy (70) per cent of the weighted volume average price (WVAP) of the Company’s shares on Nasdaq First North Growth Market during a period of ten (10) trading days immediately preceding and including, September 8, 2023, but no less than SEK 0.25 and no more than SEK 0.7 per share. The complete terms and conditions for the Warrants can be found on the Company’s website, www.coalalife.com.

Increase in number of shares and share capital

Upon exercise of all 164,979,967 Warrants, the Company’s share capital will increase with SEK 13,748,330.50 to a total of SEK 86,047,942.25 through the issuance of 54,993,322 new shares, increasing the total number of outstanding shares and votes in the Company from 289,198,447 to 344,191,769. Upon full exercise of the Warrants, the dilution of shares and votes in the Company will amount to approximately 16.0 percent.

Advisors 

Redeye AB acts as financial advisor, Setterwalls Advokatbyrå AB acts as legal advisor, and Nordic Issuing acts as issuing agent in connection with the exercise of the Warrants.

IMPORTANT INFORMATION
The information in this press release does not contain or constitute an offer to acquire, subscribe or otherwise trade in shares, warrants or other securities in the Company. An invitation to the persons concerned to subscribe for units consisting of shares in the Company and Warrants has only been made through the prospectus and supplementary prospectus approved by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen) and published on February 6, 2023 and February 14, 2023, respectively.